This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
"That is very different from a drug actually causing a new cancer." The review emphasizes that for patients with papillary, follicular, or Oncocytic (Hrthle cell) thyroid cancers, current evidence does not support the idea that GLP-1 medications cause these diseases or worsen their course
Brandon Richland, MD Wegovy, a brand name for the injectable prescription medication semaglutide, represents a newer option for individuals struggling with obesity or certain weight-related health issues
Others burned through an entire vial in a single week when it should have lasted a month
Conclusion Semaglutide offers promising benefits for bodybuilders looking to optimize their cutting phases and enhance fat loss while preserving muscle mass